Jun. 30, 2016
Israel’s BATM Advanced Communications Limited, a leading provider of real-time technologies for networking solutions and medical laboratory systems, announced on June 30, 2016 that its wholly-owned subsidiary Adaltis, a manufacturer of medical diagnostics equipment, has entered into an investment agreement and a strategic joint venture with its Chinese partner, Egens Biotechnology Company Ltd. According to the agreement, Egens will purchase ~US$3 million of Adaltis’s shares at a company valuation of ~US$58 million. Egens is to make a further investment in Adaltis Bio Med Company (a joint venture between both companies established in 2014) by way of a shareholder loan to ABC of US$1.5 million.